ATRESMED.C.D.M.D.C.EO-,75ATRESMED.C.D.M.D.C.EO-,75ATRESMED.C.D.M.D.C.EO-,75

ATRESMED.C.D.M.D.C.EO-,75

No trades
See on Supercharts

YT2A fundamentals

An in-depth look to ATRESMED.C.D.M.D.C.EO-,75 operating, investing, and financing activities

YT2A free cash flow for H1 24 is 99.04 M EUR. For 2023, YT2A free cash flow was 133.9 M EUR and operating cash flow was 163.68 M EUR.

Q3 '16
Q4 '16
Q1 '17
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q3 '16
Q4 '16
Q1 '17
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Free cash flowYoY growth